Dr Reddy's Laboratories (BSP:R1DY34) Other Stockholders Equity : R$253 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Dr Reddy's Laboratories Other Stockholders Equity?

Dr Reddy's Laboratories's Other Stockholders Equity for the quarter that ended in Dec. 2023 was R$253 Mil.

Dr Reddy's Laboratories's quarterly Other Stockholders Equity declined from Jun. 2023 (R$280 Mil) to Sep. 2023 (R$204 Mil) but then increased from Sep. 2023 (R$204 Mil) to Dec. 2023 (R$253 Mil).

Dr Reddy's Laboratories's annual Other Stockholders Equity declined from Mar. 2021 (R$603 Mil) to Mar. 2022 (R$331 Mil) and declined from Mar. 2022 (R$331 Mil) to Mar. 2023 (R$298 Mil).

Dr Reddy's Laboratories Other Stockholders Equity Historical Data

The historical data trend for Dr Reddy's Laboratories's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Other Stockholders Equity Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Stockholders Equity

Get a 7-Day Free Trial

158.74

147.34

602.67

331.28

298.02

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial															243.02	298.02	279.68	204.46	252.66

Dr Reddy's Laboratories Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Dr Reddy's Laboratories Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (BSP:R1DY34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BSP:R1DY34) » Definitions » Other Stockholders Equity

Traded in Other Exchanges

RDY:USA DRREDDY:India 500124:India RDDA:Germany RDDA:Germany

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (BSP:R1DY34) Headlines

No Headlines